Program Context and Objectives:
- Incorporated into the Quality Use of Diagnostics, Therapeutics and Pathology Program (QUDTP) from 1 July 2024 as part of the 2023-24 Budget Measure "A Modern and Clinically Appropriate Medicare Benefits Schedule."
- Aims to invest in projects that support the pathology sector and relevant stakeholders to collaborate on innovative approaches.
- Focus on improving pathology-related practices, enhancing economic efficiency, sustainability, and quality delivery of Medicare Benefits Schedule (MBS) pathology items.
- Targets improvements among requesters/referrers, providers, and consumers of pathology services.
Target Beneficiaries:
- Entities with an Australian Business Number (ABN), registered for GST, permanent residents of Australia, and with an Australian financial institution account.
- Eligible entity types include Indigenous Corporations, Companies, Corporate Commonwealth Entities, Corporate State or Territory Entities, Cooperatives, Incorporated Associations, and Partnerships.
- Consortia applications accepted if led by an eligible lead organization accountable to the Commonwealth.
Application Process:
- Applications must be submitted via the online application form (Version 2, published 12 June 2025).
- Multiple applications allowed if each meets the Quality Use of Pathology objectives.
- Attachments limited to 2MB each; multiple documents should be combined into a single file.
- Automated email confirmation with Submission Reference ID provided upon submission.
- Closing date: 7 July 2025, 2:00 pm ACT local time.
- Contact for queries: Grant.ATM@health.gov.au.
Key Features:
- Total funding pool: AUD 1,800,000.
- Grant rounds held every 2-3 years for three streams: Health Professional Education, Consumer Health Literacy, and Quality Use of Pathology (this grant).
- Projects should focus on innovation, economic efficiency, sustainability, and quality in pathology services.
- Potential delays or changes may occur if a federal election is called during the grant process.
- Only the lead organization in consortia can submit applications and enter agreements.
This grant opportunity supports collaborative, innovative projects aimed at enhancing pathology service delivery and sustainability within Australia's healthcare system.
